April 22 | 2022 Korrektion till “Kallelse till årsstämma i 2cureX AB” utfärdad den 21 april 2022 Read more
March 14 | 2022 2cureX launches IndiTreat® mCRC Explore and completes portfolio rollout plan for 2022 Read more
February 24 | 2022 2cureX publishes interim report for the fourth quarter and all 12 months of 2021 Read more
February 24 | 2022 2cureX offentliggör delårsrapport för det fjärda kvartalen och alla tolv månader 2021 Read more
January 11 | 2022 IndiTreat® to be distributed in Czech Republic and Slovakia through Promedica Read more
December 9 | 2021 2cureX signs yet another distribution agreement – this time with Omnigen Medical Products in Turkey Read more
November 25 | 2021 2cureX publishes interim report for the third quarter and first nine months of 2021 Read more
November 25 | 2021 2cureX offentliggör delårsrapport för det tredje kvartalet och första nio månader 2021 Read more
October 29 | 2021 2cureX – Banbrytande cancerbehandlingstest rullas ut – Mangold Insight Analys Read more
October 15 | 2021 2cureX successfully completed the EU-project MicroCaT and received the final financial tranche of a 3,0 MEUR grant. Read more